The transcription factor Gli3 regulates differentiation of fetal CD4 -CD8- double-negative thymocytes

47Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glioblastoma 3 (Gli3) is a transcription factor involved in patterning and oncogenesis. Here, we demonstrate a role for Gli3 in thymocyte development. Gli3 is differentially expressed in fetal CD4-CD8- double-negative (DN) thymocytes and is most highly expressed at the CD44 + CD25- DN (DN1) and CD44-CD25- (DN4) stages of development but was not detected in adult thymocytes. Analysis of null mutants showed that Gli3 is involved at the transitions from DN1 to CD44+ CD25+ DN (DN2) cell and from DN to CD4+CD8+ double-positive (DP) cell. Gli3 is required for differentiation from DN to DP thymocyte, after pre-T-cell receptor (TCR) signaling but is not necessary for pre-TCR-induced proliferation or survival. The effect of Gli3 was dose dependent, suggesting its direct involvement in the transcriptional regulation of genes controlling T-cell differentiation during fetal development. © 2005 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Hager-Theodorides, A. L., Dessens, J. T., Outram, S. V., & Crompton, T. (2005). The transcription factor Gli3 regulates differentiation of fetal CD4 -CD8- double-negative thymocytes. Blood, 106(4), 1296–1304. https://doi.org/10.1182/blood-2005-03-0998

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free